Skip to main content
Erschienen in: Current Atherosclerosis Reports 11/2014

01.11.2014 | Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)

Disease Severity and Staging of Obesity: a Rational Approach to Patient Selection

verfasst von: M. B. Whyte, S. Velusamy, S. J. B. Aylwin

Erschienen in: Current Atherosclerosis Reports | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

The increasing prevalence of obesity places ever-increasing cost demands on healthcare systems. One million individuals are eligible for bariatric surgery in the UK, and yet less than 6000 bariatric procedures are performed annually. Bariatric surgery reverses or improves almost all the medical and psychosocial co-morbidities associated with obesity. Although the BMI is a simple method to estimate adiposity at a population level, it is relatively inaccurate within an individual and provides little-to-no indication of overall health status or disease severity. Staging systems overcome the inherent limitations of BMI and allow highly informed decision-making for an individual. At a societal level, this helps to identify those most likely to gain and maximise economic benefit. This review summarises the co-morbidities associated with obesity and the evidence for their improvement following surgery. The rationale for new staging criteria and appropriate patient selection are discussed.
Literatur
1.
Zurück zum Zitat Eastwood P. Statistics on obesity. England: Physical Activity and Diet; 2013. Eastwood P. Statistics on obesity. England: Physical Activity and Diet; 2013.
2.
Zurück zum Zitat Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.PubMedCrossRefPubMedCentral Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.PubMedCrossRefPubMedCentral
3.
Zurück zum Zitat Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701.PubMed Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701.PubMed
4.
5.
Zurück zum Zitat Guerrero-Romero F, Rodriguez-Moran M. Abdominal volume index. An anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003;34(5):428–32.PubMedCrossRef Guerrero-Romero F, Rodriguez-Moran M. Abdominal volume index. An anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003;34(5):428–32.PubMedCrossRef
6.
Zurück zum Zitat Ciudin A, Salvador R, Budoy A, Ciudin A, Spinu C, Diaconu MG, et al. Measurement of waist circumference for retrospective studies—prospective validation of use of CT images to assess abdominal circumference. Endocrinol Nutr: Organo Soc Esp Endocrinol Nutr. 2014;61(3):147–52.CrossRef Ciudin A, Salvador R, Budoy A, Ciudin A, Spinu C, Diaconu MG, et al. Measurement of waist circumference for retrospective studies—prospective validation of use of CT images to assess abdominal circumference. Endocrinol Nutr: Organo Soc Esp Endocrinol Nutr. 2014;61(3):147–52.CrossRef
7.
Zurück zum Zitat Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC. A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord: J Int Assoc Study Obes. 2001;25(11):1730–5.CrossRef Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC. A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord: J Int Assoc Study Obes. 2001;25(11):1730–5.CrossRef
8.
Zurück zum Zitat Onat A, Hergenc G, Yuksel H, Can G, Ayhan E, Kaya Z, et al. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr. 2009;28(1):46–51.PubMedCrossRef Onat A, Hergenc G, Yuksel H, Can G, Ayhan E, Kaya Z, et al. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr. 2009;28(1):46–51.PubMedCrossRef
9.
Zurück zum Zitat Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. Nurses’ Health Study Am J Epidemiol. 1997;145(7):614–9.CrossRef Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. Nurses’ Health Study Am J Epidemiol. 1997;145(7):614–9.CrossRef
10.
Zurück zum Zitat Yang L, Samarasinghe YP, Kane P, Amiel SA, Aylwin SJ. Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity. Clin Endocrinol. 2010;73(2):197–200. Yang L, Samarasinghe YP, Kane P, Amiel SA, Aylwin SJ. Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity. Clin Endocrinol. 2010;73(2):197–200.
11.
Zurück zum Zitat Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39(4):578–84.PubMedCrossRef Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39(4):578–84.PubMedCrossRef
12.
Zurück zum Zitat Kalantar-Zadeh K, Streja E, Kovesdy CP, Oreopoulos A, Noori N, Jing J, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc. 2010;85(11):991–1001.PubMedCrossRefPubMedCentral Kalantar-Zadeh K, Streja E, Kovesdy CP, Oreopoulos A, Noori N, Jing J, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc. 2010;85(11):991–1001.PubMedCrossRefPubMedCentral
13.
Zurück zum Zitat Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61.PubMedCrossRef Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61.PubMedCrossRef
14.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMedCrossRef Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMedCrossRef
15.
Zurück zum Zitat Jakobsen GS, Hofso D, Roislien J, Sandbu R, Hjelmesaeth J. Morbidly obese patients—who undergoes bariatric surgery? Obes Surg. 2010;20(8):1142–8.PubMedCrossRefPubMedCentral Jakobsen GS, Hofso D, Roislien J, Sandbu R, Hjelmesaeth J. Morbidly obese patients—who undergoes bariatric surgery? Obes Surg. 2010;20(8):1142–8.PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat Romeo S, Maglio C, Burza MA, Pirazzi C, Sjoholm K, Jacobson P, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 2012;35(12):2613–7.PubMedCrossRefPubMedCentral Romeo S, Maglio C, Burza MA, Pirazzi C, Sjoholm K, Jacobson P, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 2012;35(12):2613–7.PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685–96.PubMedCrossRef Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685–96.PubMedCrossRef
18.
Zurück zum Zitat Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21 Suppl 1:S1–27.PubMedCrossRefPubMedCentral Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21 Suppl 1:S1–27.PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Aylwin S, Al-Zaman Y. Emerging concepts in the medical and surgical treatment of obesity. Front Horm Res. 2008;36:229–59.PubMedCrossRef Aylwin S, Al-Zaman Y. Emerging concepts in the medical and surgical treatment of obesity. Front Horm Res. 2008;36:229–59.PubMedCrossRef
20.••
Zurück zum Zitat Aasheim ET, Aylwin SJB, Radhakrishnan ST, Sood AS, Jovanovic A, Olbers T, et al. Assessment of obesity beyond body mass index to determine benefit of treatment. Clin Obes. 2011;1(2–3):77–84. This paper showed how individual health domains improved after bariatric surgery and provides a rationale for use of staging criteria in selecting patients for bariatric surgery.CrossRef Aasheim ET, Aylwin SJB, Radhakrishnan ST, Sood AS, Jovanovic A, Olbers T, et al. Assessment of obesity beyond body mass index to determine benefit of treatment. Clin Obes. 2011;1(2–3):77–84. This paper showed how individual health domains improved after bariatric surgery and provides a rationale for use of staging criteria in selecting patients for bariatric surgery.CrossRef
21.••
Zurück zum Zitat Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, et al. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab = Physiol Appliquee, Nutr Metab. 2011;36(4):570–6. Demonstrated how a scoring system could improve upon the BMI as a mortality predictor.CrossRef Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, et al. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab = Physiol Appliquee, Nutr Metab. 2011;36(4):570–6. Demonstrated how a scoring system could improve upon the BMI as a mortality predictor.CrossRef
22.
Zurück zum Zitat Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154(15):1705–11.PubMedCrossRef Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154(15):1705–11.PubMedCrossRef
23.
Zurück zum Zitat Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA :J Am Med Assoc. 2003;290(14):1906–14.CrossRef Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA :J Am Med Assoc. 2003;290(14):1906–14.CrossRef
24.
Zurück zum Zitat Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9):735–41.PubMedCrossRef Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9):735–41.PubMedCrossRef
25.
Zurück zum Zitat Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. Epworth Sleepiness Scale Chest. 1993;103(1):30–6. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. Epworth Sleepiness Scale Chest. 1993;103(1):30–6.
26.
Zurück zum Zitat Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. J Can Anesth. 2010;57(5):423–38.CrossRef Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. J Can Anesth. 2010;57(5):423–38.CrossRef
27.
Zurück zum Zitat Dixon JB, Schachter LM, O’Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest. 2003;123(4):1134–41.PubMedCrossRef Dixon JB, Schachter LM, O’Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest. 2003;123(4):1134–41.PubMedCrossRef
28.
Zurück zum Zitat AARC-APT (American Association of Respiratory Care-Association of Polysomnography Technologists). Clinical practice guideline. Polysomnography Respir Care. 1995;40(12):1336–43. AARC-APT (American Association of Respiratory Care-Association of Polysomnography Technologists). Clinical practice guideline. Polysomnography Respir Care. 1995;40(12):1336–43.
29.
Zurück zum Zitat Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Cote CJ, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006;104(5):1081–93. quiz 117-8.PubMedCrossRef Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Cote CJ, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006;104(5):1081–93. quiz 117-8.PubMedCrossRef
30.
Zurück zum Zitat Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.PubMedCrossRef Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.PubMedCrossRef
31.
Zurück zum Zitat Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720–8.PubMedCrossRef Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720–8.PubMedCrossRef
32.
Zurück zum Zitat Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77.PubMedCrossRef Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77.PubMedCrossRef
33.
Zurück zum Zitat Prospective Studies C, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.CrossRef Prospective Studies C, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.CrossRef
34.
Zurück zum Zitat Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes care. 2000;23(10):1499–504.PubMedCrossRef Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes care. 2000;23(10):1499–504.PubMedCrossRef
35.
Zurück zum Zitat Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321(4):225–36.PubMedCrossRef Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321(4):225–36.PubMedCrossRef
36.
Zurück zum Zitat Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993;88(4 Pt 1):1431–6.PubMedCrossRef Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993;88(4 Pt 1):1431–6.PubMedCrossRef
37.
Zurück zum Zitat McCloskey CA, Ramani GV, Mathier MA, Schauer PR, Eid GM, Mattar SG, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2007;3(5):503–7.CrossRef McCloskey CA, Ramani GV, Mathier MA, Schauer PR, Eid GM, Mattar SG, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2007;3(5):503–7.CrossRef
38.
Zurück zum Zitat Miranda WR, Batsis JA, Sarr MG, Collazo-Clavell ML, Clark MM, Somers VK, et al. Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg. 2013;23(7):1011–5.PubMedCrossRef Miranda WR, Batsis JA, Sarr MG, Collazo-Clavell ML, Clark MM, Somers VK, et al. Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg. 2013;23(7):1011–5.PubMedCrossRef
39.
Zurück zum Zitat Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.PubMedCrossRef Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.PubMedCrossRef
40.•
Zurück zum Zitat Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. The Swedish Obesity Study is a landmark trial of outcomes after bariatric surgery. This paper highlights the cardiovascular benefit of bariatric surgery.PubMedCrossRef Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. The Swedish Obesity Study is a landmark trial of outcomes after bariatric surgery. This paper highlights the cardiovascular benefit of bariatric surgery.PubMedCrossRef
41.
Zurück zum Zitat Kwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8.PubMedCrossRef Kwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8.PubMedCrossRef
42.
Zurück zum Zitat Look ARG, Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14(5):737–52.CrossRef Look ARG, Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14(5):737–52.CrossRef
43.
Zurück zum Zitat Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.PubMedCrossRefPubMedCentral Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.PubMedCrossRefPubMedCentral
44.
Zurück zum Zitat Brethauer SA, Aminian A, Romero-Talamas H, Batayyah E, Mackey J, Kennedy L, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 36-7.PubMedPubMedCentral Brethauer SA, Aminian A, Romero-Talamas H, Batayyah E, Mackey J, Kennedy L, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 36-7.PubMedPubMedCentral
45.•
Zurück zum Zitat Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704. Showed that surgery is more effective at preventing the onset of type 2 diabetes than conventional therapy.PubMedCrossRef Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704. Showed that surgery is more effective at preventing the onset of type 2 diabetes than conventional therapy.PubMedCrossRef
46.
Zurück zum Zitat Ogden J, Clementi C, Aylwin S, Patel A. Exploring the impact of obesity surgery on patients’ health status: a quantitative and qualitative study. Obes Surg. 2005;15(2):266–72.PubMedCrossRef Ogden J, Clementi C, Aylwin S, Patel A. Exploring the impact of obesity surgery on patients’ health status: a quantitative and qualitative study. Obes Surg. 2005;15(2):266–72.PubMedCrossRef
47.
Zurück zum Zitat Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, et al. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia. 1997;40(11):1341–9.PubMedCrossRef Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, et al. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia. 1997;40(11):1341–9.PubMedCrossRef
48.
Zurück zum Zitat Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes. 2007;31(8):1248–61.CrossRef Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes. 2007;31(8):1248–61.CrossRef
49.
Zurück zum Zitat Turchiano M, Saunders JK, Fernandez G, Navie L, Labrador L, Parikh M. Bariatric surgery may improve employment status in unemployed, underserved, severely obese patients. Obes Surg. 2014;24(5):692–5.PubMedCrossRef Turchiano M, Saunders JK, Fernandez G, Navie L, Labrador L, Parikh M. Bariatric surgery may improve employment status in unemployed, underserved, severely obese patients. Obes Surg. 2014;24(5):692–5.PubMedCrossRef
50.
Zurück zum Zitat Nicolai A, Ippoliti C, Petrelli MD. Laparoscopic adjustable gastric banding: essential role of psychological support. Obes Surg. 2002;12(6):857–63.PubMedCrossRef Nicolai A, Ippoliti C, Petrelli MD. Laparoscopic adjustable gastric banding: essential role of psychological support. Obes Surg. 2002;12(6):857–63.PubMedCrossRef
51.
Zurück zum Zitat Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes. 2007;14(6):482–7.PubMedCrossRef Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes. 2007;14(6):482–7.PubMedCrossRef
52.
Zurück zum Zitat Hakonsen LB, Thulstrup AM, Aggerholm AS, Olsen J, Bonde JP, Andersen CY, et al. Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men. Reprod Health. 2011;8:24.PubMedCrossRefPubMedCentral Hakonsen LB, Thulstrup AM, Aggerholm AS, Olsen J, Bonde JP, Andersen CY, et al. Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men. Reprod Health. 2011;8:24.PubMedCrossRefPubMedCentral
53.
Zurück zum Zitat Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004;19(7):1644–6.PubMedCrossRef Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004;19(7):1644–6.PubMedCrossRef
54.
Zurück zum Zitat Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13(6):1502–5.PubMedCrossRef Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13(6):1502–5.PubMedCrossRef
55.
Zurück zum Zitat Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg. 2006;16(11):1457–63.PubMedCrossRef Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg. 2006;16(11):1457–63.PubMedCrossRef
56.
Zurück zum Zitat Weintraub AY, Levy A, Levi I, Mazor M, Wiznitzer A, Sheiner E. Effect of bariatric surgery on pregnancy outcome. Int J Gynaecol Obstet:Off Organ Int Fed Gynaecol Obstet. 2008;103(3):246–51.CrossRef Weintraub AY, Levy A, Levi I, Mazor M, Wiznitzer A, Sheiner E. Effect of bariatric surgery on pregnancy outcome. Int J Gynaecol Obstet:Off Organ Int Fed Gynaecol Obstet. 2008;103(3):246–51.CrossRef
57.
Zurück zum Zitat Dalfra MG, Busetto L, Chilelli NC, Lapolla A. Pregnancy and foetal outcome after bariatric surgery: a review of recent studies. J Matern-fetal Neonatal Med: Off J Eur Assoc Perinatal Med, Fed Asia Oceania Perinatal Soc Int Soc Perinatal Obstet. 2012;25(9):1537–43.CrossRef Dalfra MG, Busetto L, Chilelli NC, Lapolla A. Pregnancy and foetal outcome after bariatric surgery: a review of recent studies. J Matern-fetal Neonatal Med: Off J Eur Assoc Perinatal Med, Fed Asia Oceania Perinatal Soc Int Soc Perinatal Obstet. 2012;25(9):1537–43.CrossRef
58.
Zurück zum Zitat Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.PubMedCrossRef Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.PubMedCrossRef
59.
Zurück zum Zitat Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am. 2001;81(5):1063–75.PubMedCrossRef Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am. 2001;81(5):1063–75.PubMedCrossRef
60.
Zurück zum Zitat Vella VL, Jaffe W, Lidicker J, Meilahn J, Dandolu V. Prevalence of urinary symptoms in morbidly obese women and changes after bariatric surgery. J Reprod Med. 2009;54(10):597–602.PubMed Vella VL, Jaffe W, Lidicker J, Meilahn J, Dandolu V. Prevalence of urinary symptoms in morbidly obese women and changes after bariatric surgery. J Reprod Med. 2009;54(10):597–602.PubMed
61.
Zurück zum Zitat Clements RH, Gonzalez QH, Foster A, Richards WO, McDowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.PubMedCrossRef Clements RH, Gonzalez QH, Foster A, Richards WO, McDowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.PubMedCrossRef
62.
Zurück zum Zitat Sugerman HJ, Felton 3rd WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634–40. discussion 40-2.PubMedCrossRefPubMedCentral Sugerman HJ, Felton 3rd WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634–40. discussion 40-2.PubMedCrossRefPubMedCentral
63.
Zurück zum Zitat Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol: JASN. 2006;17(6):1695–702.PubMedCrossRef Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol: JASN. 2006;17(6):1695–702.PubMedCrossRef
64.
Zurück zum Zitat Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA: J Am Med Assoc. 2004;291(7):844–50.CrossRef Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA: J Am Med Assoc. 2004;291(7):844–50.CrossRef
65.
Zurück zum Zitat Bayliss G, Weinrauch LA, D’Elia JA. Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Curr Diabetes Rep. 2012;12(4):440–6.CrossRef Bayliss G, Weinrauch LA, D’Elia JA. Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Curr Diabetes Rep. 2012;12(4):440–6.CrossRef
66.
Zurück zum Zitat Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sjoholm K, et al. The incidence of albuminuria after bariatric surgery and usual care in Swedish obese subjects (SOS): a prospective controlled intervention trial. International Journal of Obesity. 2014. Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sjoholm K, et al. The incidence of albuminuria after bariatric surgery and usual care in Swedish obese subjects (SOS): a prospective controlled intervention trial. International Journal of Obesity. 2014.
67.
Zurück zum Zitat Hou CC, Shyu RS, Lee WJ, Ser KH, Lee YC, Chen SC. Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2013;9(2):202–6.CrossRef Hou CC, Shyu RS, Lee WJ, Ser KH, Lee YC, Chen SC. Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2013;9(2):202–6.CrossRef
68.
Zurück zum Zitat Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430–5.PubMedCrossRefPubMedCentral Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430–5.PubMedCrossRefPubMedCentral
69.
70.
Zurück zum Zitat Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology. 2012;55(5):1406–15.PubMedCrossRef Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology. 2012;55(5):1406–15.PubMedCrossRef
71.
Zurück zum Zitat Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2008;6(12):1396–402.CrossRef Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2008;6(12):1396–402.CrossRef
72.•
Zurück zum Zitat Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ : Can Med Assoc J = J’Assoc Med Canad. 2011;183(14):E1059–66. This paper showed that the presence of a severe complication affects survival in all grades of obesity. This highlights the importance of obesity staging.CrossRef Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ : Can Med Assoc J = J’Assoc Med Canad. 2011;183(14):E1059–66. This paper showed that the presence of a severe complication affects survival in all grades of obesity. This highlights the importance of obesity staging.CrossRef
Metadaten
Titel
Disease Severity and Staging of Obesity: a Rational Approach to Patient Selection
verfasst von
M. B. Whyte
S. Velusamy
S. J. B. Aylwin
Publikationsdatum
01.11.2014
Verlag
Springer US
Erschienen in
Current Atherosclerosis Reports / Ausgabe 11/2014
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-014-0456-7

Weitere Artikel der Ausgabe 11/2014

Current Atherosclerosis Reports 11/2014 Zur Ausgabe

Clinical Trials and Their Interpretations (JR Kizer, Section Editor)

Role of Novel Anticoagulants for Patients with Mechanical Heart Valves

Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)

Bariatric Surgery and Microvascular Complications of Type 2 Diabetes Mellitus

Clinical Trials and Their Interpretations (JR Kizer, Section Editor)

N-3 Fatty Acids for Prevention of Cardiovascular Disease

Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)

Lipidomic Profiling at the Interface of Metabolic Surgery and Cardiovascular Disease

Clinical Trials and Their Interpretations (JR Kizer, Section Editor)

Antiplatelet Strategies for Secondary Prevention of Stroke and TIA

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.